Alexander Jan, Olsen Ann-Karin
Norwegian Institute of Public Health, Oslo, Norway.
Food Nutr Res. 2023 Dec 28;67. doi: 10.29219/fnr.v67.10320. eCollection 2023.
Selenium is an essential trace element in humans, critical to the normal physiology in all animal species. The main form of selenium in food is selenomethionine, selenocysteine and a variety of organic compounds, while inorganic salts mainly occur in food supplements. In animals and humans, selenium occurs as selenocysteine in selenoproteins encoded by 25 genes (specific selenium pool). Several selenoproteins are part of the antioxidant enzyme system and serve as oxido-reductases and in thyroid hormone regulation. SelenoproteinP (SELENOP) transports selenium to peripheral tissues, is the main plasma selenoprotein, and has been used as biomarker of selenium status and intake. SELENOP in plasma represents a saturable pool of selenium and is maximised at a selenium concentration in plasma of about 110 µg/L or an intake of selenomethionine at about 1.2 µg/kg body weight in adults. In Finland, with an estimated selenium intake of 88 µg/day in men and 68 µg/day in women, the average selenium concentration in plasma is about 110 µg/L. Imported wheat from selenium rich areas is an important dietary source in Norway. Dietary intakes in the Nordic and Baltic area vary from 39 to 88 µg/day in men and 22 to 68 µg/day in women, the highest levels were from Finland. Most intervention trials on the effect of selenium supplementation on health outcomes have been carried out in 'selenium-replete'-populations and show no beneficial effect, which from a nutritional point of view would rather not be expected. Some intervention studies conducted in populations low in selenium have showed a beneficial effect. Observational studies suggest an inverse relationship between selenium status and risk of cardiovascular diseases (CVDs), cancer and all-cause mortality, and some other outcomes at low levels of intake (<55 µg/day) or in plasma or serum (<100 µg/L). However, a lack of quantitative data and inconsistencies between studies precludes these studies to be used to derive dietary reference values. At high intakes above 330 to 450 µg/day selenium may cause toxic effects affecting liver, peripheral nerves, skin, nails, and hair. An upper tolerable level (UL) of 255 µg selenium/day in adults was established by EFSA.
硒是人体必需的微量元素,对所有动物物种的正常生理功能都至关重要。食物中硒的主要形式是硒代蛋氨酸、硒代半胱氨酸和多种有机化合物,而无机盐主要存在于食品补充剂中。在动物和人类中,硒以硒代半胱氨酸的形式存在于由25个基因编码的硒蛋白中(特定硒池)。几种硒蛋白是抗氧化酶系统的一部分,充当氧化还原酶并参与甲状腺激素调节。硒蛋白P(SELENOP)将硒转运到外周组织,是主要的血浆硒蛋白,并已被用作硒状态和摄入量的生物标志物。血浆中的SELENOP代表一个可饱和的硒池,在成年人血浆中硒浓度约为110μg/L或硒代蛋氨酸摄入量约为1.2μg/kg体重时达到最大值。在芬兰,男性估计硒摄入量为88μg/天,女性为68μg/天,血浆中硒的平均浓度约为110μg/L。从富硒地区进口的小麦是挪威重要的饮食来源。北欧和波罗的海地区的饮食摄入量男性为39至88μg/天,女性为22至68μg/天,最高水平来自芬兰。大多数关于补充硒对健康结果影响的干预试验是在“硒充足”人群中进行的,没有显示出有益效果,从营养角度来看,这是意料之中的。在低硒人群中进行的一些干预研究显示出有益效果。观察性研究表明,在低摄入量(<55μg/天)或血浆或血清中硒水平较低(<100μg/L)时,硒状态与心血管疾病(CVD)、癌症和全因死亡率以及其他一些结果的风险呈负相关。然而,缺乏定量数据以及研究之间的不一致性使得这些研究无法用于得出膳食参考值。当硒摄入量高于3